You are viewing: US Pharmaceutical Packaging Market analysis

The US Pharmaceutical Packaging Market was valued at $42668.8 Million in 2025 and projected to reach to $84682.9 Million by 2030, representing a compound annual growth rate of 14.7%. The US pharmaceutical packaging market is poised for sustained expansion through 2030, driven by increasing FDA regulatory scrutiny, the proliferation of biologics, and heightened focus on patient safety and drug integrity.

US Pharmaceutical Packaging Market Trends and Insights

  • This expansion reflects the US healthcare sector's increasing demand for advanced, compliant, and sustainable packaging solutions that protect drug integrity and enhance patient safety.
  • The US market is driven by stringent FDA regulations, rising pharmaceutical production volumes, and the growing adoption of innovative packaging technologies including child-resistant containers, tamper-evident seals, and smart packaging systems. In the US, the pharmaceutical packaging sector is benefiting from accelerated growth in biologics, specialty pharmaceuticals, and personalized medicine, all requiring specialized containment solutions.
  • The US market's 14.7% compound annual growth rate significantly reflects the nation's position as a global pharmaceutical manufacturing hub and the increasing complexity of drug formulations.
  • Between 2025 and 2030, the US pharmaceutical packaging market will nearly double in value, driven by regulatory compliance requirements, supply chain resilience initiatives, and the shift toward eco-friendly materials that align with sustainability mandates..

Key Market Statistics

  • CAGR (2025-2030) 14.7% CAGR
  • Market Size, 2025 ~USD 42668.8 Million
  • Forecast, 2030 ~USD 84682.9 Million
  • Country US

US Pharmaceutical Packaging Market Overview

Market Valuation Growth :

The US pharmaceutical packaging market is valued at $42,668.8 million in 2025 and is projected to reach $84,682.9 million by 2030, representing a robust 14.7% CAGR driven by FDA compliance requirements and drug safety innovations.

FDA Regulatory Compliance :

Stringent FDA regulations mandate advanced packaging solutions for drug protection and patient safety, compelling US pharmaceutical manufacturers to invest in compliant, high-quality packaging materials and technologies.

Sustainability Initiatives :

US pharmaceutical companies are increasingly adopting eco-friendly and sustainable packaging solutions to meet environmental regulations and consumer expectations, driving demand for innovative, recyclable materials.

Biopharmaceutical Expansion :

The rapid growth of biologics and specialty pharmaceuticals in the US market requires specialized, temperature-controlled, and tamper-evident packaging solutions, creating significant opportunities for advanced packaging providers.

US Pharmaceutical Packaging Market Dynamics

  • Manufacturers are investing heavily in smart packaging technologies, including serialization and track-and-trace capabilities, to combat counterfeiting and enhance supply chain transparency.
  • The market will continue to benefit from the aging US population, rising chronic disease prevalence, and growing demand for personalized medicine solutions that require specialized packaging formats and delivery mechanisms..

Related Ecosystem

Resins And Polymers

Top Technologies
  • Polycarbonate
  • Acrylonitrile Butadiene Styrene (ABS)
  • Epoxy Resin
  • Light Commercial Vehicles (LCVs)
  • Polypropylene (PP)
Top Companies
  • Basf se
  • DOW CHEMICAL COMPANY
  • Solvay sa
  • Saudi arabia basic industries corporation (sabic)
  • DuPont de Nemours, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Packaging

      Top Technologies
      • Ampoules
      • Gravure Process
      • Rigid Packaging
      • Aerosols
      • Aseptic Filling and Sealing Equipment
      Top Companies
      • Amcor plc
      • Essentra plc
      • Berry Global Group, Inc.
      • Mondi plc
      • SEALED AIR CORPORATION

        Key Takeaways

        • The US pharmaceutical packaging market will nearly double from $42.67B (2025) to $84.68B (2030), representing a 14.7% CAGR.
        • US regulatory compliance and FDA requirements drive demand for advanced packaging technologies including child-resistant and tamper-evident solutions.
        • The US market benefits from growth in biologics and specialty pharmaceuticals, which require specialized, high-performance containment systems.
        • Sustainability and eco-friendly materials are reshaping the US pharmaceutical packaging landscape as manufacturers prioritize environmental compliance.

        Pharmaceutical Packaging Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment PREFILLED SYRINGES (Type)
        Forecast Period 2025–2030
        Growth Rate CAGR of 15.8% from 2025 to 2030
        Largest Segment INJECTABLE (Drug Delivery)
        Market Size Base Year (Billions) ~USD 174.86 (2025)
        Revenue Forecast (Billions) ~USD 364.11 (2030)
        Segments Covered Raw Material, Drug Delivery, Type, Packaging Type, Drug Delivery Mode

        US Pharmaceutical Packaging Market Report Segmentation

        5 segment dimensions are covered across the global market.

        By Raw Material

        • Glass
        • Metal
        • Other Raw Materials
        • Paper & Paperboard
        • Plastic
        • Plastics

        By Drug Delivery

        • Injectable
        • Injectables
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Oral Drugs
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        By Type

        • Ampoules
        • Blister Packs
        • Caps & Closures
        • Cartridges
        • Jars & Canisters
        • Labels & Accessories
        • Medical Specialty Bags
        • Medication Tubes
        • Other Types
        • Plastic Bottles
        • Pouches & Strip Packs
        • Pouches & Strips
        • Prefilled Inhalers
        • Prefilled Syringes
        • Temperature-Controlled Packaging
        • Vials

        By Packaging Type

        • Primary
        • Secondary

        By Drug Delivery Mode

        • Injectable
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        Target Audience

        • Pharmaceutical Manufacturers : US-based and multinational pharma companies need market intelligence to optimize packaging strategies, ensure FDA compliance, and identify cost-effective solutions that enhance product differentiation and patient safety.
        • Packaging Material Suppliers : Suppliers of plastics, glass, metals, and specialty materials require US market data to forecast demand, develop compliant products, and capitalize on growth opportunities in biologics and specialty drug packaging.
        • Contract Packaging Organizations (CPOs) : US-based CPOs need market insights to expand service offerings, invest in advanced technologies, and position themselves competitively to serve growing demand from pharmaceutical manufacturers.
        • Healthcare & Regulatory Consultants : Consultants advising pharmaceutical companies on compliance and market strategy require detailed US market data to provide informed recommendations on packaging solutions and regulatory navigation.
        • Investment & Private Equity Firms : Investors evaluating opportunities in the US pharmaceutical packaging sector need comprehensive market analysis, growth projections, and competitive intelligence to identify high-potential acquisition and investment targets.

        Key Companies in the US Pharmaceutical Packaging Market

        CompanyHQOwnershipStrongest segments
        TASNEESaudi ArabiaPublic CompanyPetrochemicals (PE, PP compounds, acrylics, solvents),Metallurgy (titanium sponge, slag, pig iron, lead),Downstream plastics (BOPP films, pipes, pallets, agrifilm, sheets, liners),
        LG CHEM LTD.South KoreaPublic CompanyEthylene- and propylene-based synthetic resins,Styrene-based resins and polycarbonate,Advanced materials and battery-related chemistries,
        BOBST GROUP SASwitzerlandPrivate CompanyFolding carton converting (flatbed die-cutters, folder-gluers, related tooling and services),Corrugated board equipment (flexo printing, rotary die-cutters, folder-gluers, converting lines),Flexible packaging and label equipment (vacuum metallizers, coating/laminating, CI/inline flexo, gravure, digital),
        GERRESHEIMER AGGermanyPublic CompanyPrimary Packaging Glass (vials, cartridges, ampoules, flacons),Plastics & Devices (syringes, bottles, closures, medical disposables),Advanced Technologies & Drug Delivery Devices,
        SCHOTT AGGermanyPublic CompanyPrefillable glass syringes (syriQ portfolio),Pharmaceutical glass vials (adaptiQ, EVERIC family),Cartridges (cartriQ and related),
        APTARGROUP, INC.United StatesPublic CompanyPharma (drug delivery, elastomeric components, active material science, digital health),Beauty (fragrance, facial skincare, color cosmetics dispensing),Closures (food, beverage, personal and home care closures and aerosol valves),
        BDUnited StatesPublic Company
        WESTROCK COMPANYUnited StatesPrivate CompanyConsumer packaging solutions,Corrugated packaging solutions,Merchandising display solutions,

        TASNEE

        TASNEE is a Saudi Arabian public company founded in 1984 with 7,000 employees, operating in the petrochemicals and industrial materials industry.

        LG CHEM LTD.

        LG Chem Ltd. is a South Korean public company founded in 1947 with 14,019 employees, specializing in chemicals, advanced materials, and energy solutions.

        BOBST GROUP SA

        Bobst Group SA is a Swiss private company founded in 1890 with 6,314 employees, manufacturing machinery and equipment for the packaging and printing industries.

        GERRESHEIMER AG

        Gerresheimer AG is a German public company founded in 1864 with 13,528 employees, manufacturing specialty glass and plastic packaging for pharmaceuticals and cosmetics.

        SCHOTT AG

        Schott AG is a German public company founded in 1884 with 4,839 employees, producing specialty glass and glass-ceramics for various industrial applications.

        APTARGROUP, INC.

        AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees, manufacturing dispensing systems and packaging solutions for beauty, personal care, and pharmaceutical markets.

        BD

        BD (Becton, Dickinson and Company) is a United States public company founded in 1897 with 72,000 employees, specializing in medical devices, diagnostics, and laboratory equipment.

        WESTROCK COMPANY

        WestRock Company is a United States private company founded in 2018 with 56,100 employees, operating as a major manufacturer of paper and packaging products.

        Reasons to Buy this Report

        • Market Size & Growth Projections : Access precise valuation data showing the US market growing from $42.7B to $84.7B by 2030, enabling accurate financial forecasting and investment planning for pharmaceutical packaging ventures.
        • FDA Regulatory Insights : Understand stringent US regulatory requirements and compliance standards that shape packaging innovation, helping manufacturers develop solutions that meet FDA mandates and avoid costly non-compliance penalties.
        • Competitive Landscape Analysis : Identify key players, market consolidation trends, and competitive positioning within the US pharmaceutical packaging sector to inform strategic partnerships, acquisitions, and market entry strategies.
        • Technology & Innovation Trends : Discover emerging packaging technologies including smart packaging, serialization, and track-and-trace systems driving US market differentiation and enabling premium positioning in a competitive landscape.
        • Segment & Application Breakdown : Gain detailed insights into packaging types, therapeutic categories, and end-user segments specific to the US market, enabling targeted product development and go-to-market strategies.

        Frequently asked questions

        What is the current size of the US pharmaceutical packaging market?

        The US pharmaceutical packaging market is valued at $42,668.8 million in 2025 and is expected to grow to $84,682.9 million by 2030.

        What is the growth rate of the US pharmaceutical packaging market?

        The US pharmaceutical packaging market is growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2030.

        What factors are driving growth in the US pharmaceutical packaging market?

        Key drivers include stringent FDA regulations, rising pharmaceutical production volumes, demand for biologics and specialty pharmaceuticals, and the adoption of sustainable, innovative packaging technologies.

        Which packaging technologies are most in demand in the US market?

        The US market shows strong demand for child-resistant containers, tamper-evident seals, smart packaging systems, and sustainable materials that meet regulatory and environmental standards.

        How will the US pharmaceutical packaging market evolve by 2030?

        By 2030, the US market will nearly double in value, with increased adoption of eco-friendly materials, advanced compliance technologies, and specialized solutions for complex drug formulations.

        RESEARCH METHODOLOGY

        The study involved four major activities to estimate the current size of the global pharmaceutical packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the pharmaceutical packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

        Secondary Research

        The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the pharmaceutical packaging market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the pharmaceutical packaging market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Pharmaceutical Packaging Market Size, and Share

        Notes: Other designations include sales, marketing, and product managers.
        Tier 1: Revenues greater than USD 1 Billion; Tier 2: Revenues between USD 500 million and USD 1
        Billion; and Tier 3: Revenues less than USD 500 million

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        The top-down and bottom-up approaches were used to estimate and validate the size of the global pharmaceutical packaging market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

        Pharmaceutical Packaging Market : Top-Down and Bottom-Up Approach

        Pharmaceutical Packaging Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

        Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

        Stakeholders

        • Pharmaceutical packaging manufacturers
        • Raw material suppliers
        • Converters & processors
        • Distributors and traders
        • Industry associations and regulatory bodies
        • End users

        Report Objectives

        • To define, describe, and forecast the size of the pharmaceutical packaging market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
        • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
        • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
        • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
        • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
        • To strategically profile key players and comprehensively analyze their market shares and core competencies
        • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the pharmaceutical packaging market
        • To provide the impact of AI/Gen AI on the market

        Available Customizations

        With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

        The following customization options are available for the pharmaceutical packaging market report:

        Product Analysis

        • A product matrix that gives a detailed comparison of the product portfolio of each company

        Geographic Analysis as per Feasibility

        • A further breakdown of the pharmaceutical packaging market for additional countries

        Company Information

        • Detailed analysis and profiling of additional market players (up to five)

        Get the Full Pharmaceutical Packaging Market Report

        Full forecast, segment splits, and company analysis for all Pharmaceutical Packaging Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status